Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
Dieleman E, van der Woude L, van Os R, van Bockel L, Coremans I, van Es C, De Jaeger K, Knol HP, Kolff W, Koppe F, Pomp J, Reymen B, Schinagl D, Spoelstra F, Tissing-Tan C, van der Voort van Zyp N, van der Wel A, Wijsman R, Dielwart M, Wiegman E, Damhuis R, Belderbos J. Dieleman E, et al. Among authors: spoelstra f. Clin Lung Cancer. 2023 Mar;24(2):130-136. doi: 10.1016/j.cllc.2022.11.008. Epub 2022 Nov 25. Clin Lung Cancer. 2023. PMID: 36572596 Free article.
Diagnostic challenges in survivors of early stage lung cancer.
van Iersel-Vet MT, Thunnissen E, Spoelstra FO, Ylstra B, Slotman BJ, Senan S. van Iersel-Vet MT, et al. Lung Cancer. 2015 Nov;90(2):212-6. doi: 10.1016/j.lungcan.2015.08.013. Epub 2015 Aug 24. Lung Cancer. 2015. PMID: 26323215
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer.
Ronden MI, Bahce I, Hashemi SMS, Dickhoff C, de Haan PF, Becker A, Spoelstra FOB, Dahele MR, Ali R, Tiemessen MA, Tarasevych S, Maassen van den Brink K, Haasbeek CJA, Daniels JMA, van Laren M, Verbakel WFAR, Senan S. Ronden MI, et al. Among authors: spoelstra fob. Lung Cancer. 2021 Feb;152:149-156. doi: 10.1016/j.lungcan.2020.12.019. Epub 2020 Dec 24. Lung Cancer. 2021. PMID: 33418430
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis.
Ronden MI, Bahce I, Claessens NJM, Barlo N, Dahele MR, Daniels JMA, Tissing-Tan C, Hekma E, Hashemi SMS, van der Wel A, Spoelstra FOB, Verbakel WFAR, Tiemessen MA, van Laren M, Becker A, Tarasevych S, Haasbeek CJA, Maassen van den Brink K, Dickhoff C, Senan S. Ronden MI, et al. Among authors: spoelstra fob. JTO Clin Res Rep. 2021 Jun 6;2(7):100195. doi: 10.1016/j.jtocrr.2021.100195. eCollection 2021 Jul. JTO Clin Res Rep. 2021. PMID: 34590040 Free PMC article.
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy.
van Rossum PSN, Wolfhagen N, van Bockel LW, Coremans IEM, van Es CA, van der Geest AM, De Jaeger KEA, Wachters B, Knol HP, Koppe FLA, Pomp J, Reymen BJT, Schinagl DAX, Spoelstra FOB, Tissing-Tan CJA, Peters M, van der Voort van Zijp NCMG, van der Wel AM, Wiegman EM, Wijsman R, Damhuis RAM, Belderbos JSA. van Rossum PSN, et al. Among authors: spoelstra fob. J Thorac Oncol. 2024 Nov;19(11):1550-1563. doi: 10.1016/j.jtho.2024.07.016. Epub 2024 Jul 25. J Thorac Oncol. 2024. PMID: 39067700 Free article.
Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer.
Remmerts de Vries IF, Ronden MI, Bahce I, Spoelstra FOB, De Haan PF, Haasbeek CJA, Lissenberg-Witte BI, Slotman BJ, Dahele M, Verbakel WFAR. Remmerts de Vries IF, et al. Among authors: spoelstra fob. Cancers (Basel). 2021 Nov 25;13(23):5923. doi: 10.3390/cancers13235923. Cancers (Basel). 2021. PMID: 34885034 Free PMC article.
41 results